India, Nov. 4 -- Healthcare stocks attracted investor attention following a series of clinical, financial and strategic developments. Lyell Immunopharma led the gains after securing approximately $80 million in private placement financing and reporting encouraging ronde-cel data. LivaNova and UFP Technologies advanced after delivering strong quarterly results and improving profitability, while Neuronetics gained as its third-quarter loss narrowed and adjusted EBITDA turned positive.
Read on.....
Lyell Immunopharma, Inc. (LYEL)
Shares surged 44% following an approximately $80 million private placement and positive clinical data for its investigational CAR T-cell therapy, ronde-cel. Response rates reached 91% in the third-line or later coh...